The natural ingredients in MYOPEP activate a multi-dimensional cascade of fat loss processes primarily through myostatin-inhibition.


MYOPEP’s colostrum is enriched and purified with follistatin peptides (as natural colostrum derivatives) that may reduce fat production (adipogenesis), and increase fat breakdown (lipolysis) and enhance lean muscle gain by inhibiting myostatin.

The fortification of MYOPEP’s formula with a combination of purified botanical ingredients (proven to engender specific weight controlling qualities) may address multiple underlying issues of obesity, weight gain and metabolic disorders.

The discovery of TGF-β superfamily follistatin peptide (an amino acid complex that suppresses myostatin function to cause increased metabolism and reduced fat production) is exciting the medical and scientific communities.

The idea of MYOPEP’s developers was to manage weight and improve fitness by inhibiting myostatin with follistatin peptides was tested by hundreds of market experts in Geneva*.

Today, myostatin-inhibition using follistatin peptides is a new, proven and thoughtleading science in the global weight loss and fitness industry, and serves as a strong and unique competitive offering to this growing market.

*Nutraceutical Business & Technology Awards 2012 in Geneva, Switzerland.

MYOPEP’s colostrum contains natural peptides belonging to TGF-β superfamily that are enriched and purified into concentrated amount of active derivatives using a unique and patentable ‘selective peptide purification and enrichment technology’. This represents a technological milestone for the industry, as no others are able to derive natural follistatin peptides in a scalable production format.

The mechanism of action of follistatin peptides involves the blocking of myostatin to directly influence the differentiation pathways of mesenchymal stem cells towards repairing damaged or old musculoskeletal cells and regenerating new muscle cells, ultimately (1) reducing the recruitment of mesenchymal stem cells for adipogenesis to decrease fat production and (2) stimulating muscle activity to increase fat breakdown (lipolysis). This mechanism of action is scientifically rooted with a large array of existing research and published journals.

The inhibition of fat production and stimulation of fat breakdown with follistatin has been trialed and proven to be highly effective in weight management and fitness enhancement, under various clinical parameters including studies on genetically myostatin-deficient subjects.

MYOPEP has regulatory certification from Therapeutic Goods Administration (TGA) in one of the most highly regulated markets in the world, Australia. This regulatory certification represents a validation of MYOPEP’s safety and efficacy for weight loss and lean muscle gain. .